THERAPEUTIC APPROACHES TO THE URTICARIA TREATMENT
- 作者: Shvets SM1
-
隶属关系:
- Institute of Immunology
- 期: 卷 9, 编号 2 (2012)
- 页面: 61-64
- 栏目: Articles
- URL: https://bakhtiniada.ru/raj/article/view/121201
- DOI: https://doi.org/10.36691/RJA733
- ID: 121201
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
Urticaria is a heterogenic disorder, requires elimination of triggers and symptomatic treatment. The basic medications are antihistaminics of the second generation.
参考
- EAACI/GA2LEN/EDF/WAO guideline: management of urticaria Allergy. 2009, v. 64, р. 1427-1443.
- Российский национальный согласительный документ. Крапивница и ангиоотек. Рекомендации для практических врачей. М., «Фармарус Принт Медиа», 2007, 128 с.
- EAACI/GA2LEN/EDF guideline: management of urticaria Allergy. 2006, v. 61, p. 321-331.
- EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009, v. 64, р. 1417-1426.
- Church M.K., Mauer M., Simons F.E. et Risk of first-generation H,-antihistamines: a GA2LEN position paper. Allergy 2010, v. 65, p. 459-466.
- Гущин И.С. Аллергическое воспаление и его фармакологический контроль. М., «Фармарус Принт». 1998, 252 с.
- Gillman S., Gillard M., Strolin Benedetti M. The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H,-antihistamines. Allergy Asthma Proc. 2009, v. 30 (4), p. 366-376.
- Jauregui I., Ferrer M., Montoro L. et al. Anyihistamines in the treatment of chronic urticaria. J. Investig. Allergol. Clin. Immunol. 2007, v. 17, Suppl. 2, p. 41-52.
- Nettis E., Colanardi M.C., Barra L. et al. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. J. Dermatol. 2006, v. 154 (3), p. 533-538.
- Potter P.C., Kapp A., Maurer M. et al. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy. 2009, v. 64 (4), p. 596-604.
补充文件
